A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Name: A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
Published: 2015
License: Public Domain

Janssen Research & Development, LLC · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

liquidchromatography schizophrenia

schizophrenia, schizoaffective disorder, aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, liquid chromatography-tandem mass spectrometry, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Related documents